Pertussis Fact Sheet
... The current acellular pertussis vaccines are safer than whole-cell pertussis vaccines (DTPw) previously used in Australia. Acellular pertussis vaccines are associated with a much lower incidence of fever (20% vs 45%) and local reactions (10% vs 40%) than DTPw vaccine.18 Serious side effects are rare ...
... The current acellular pertussis vaccines are safer than whole-cell pertussis vaccines (DTPw) previously used in Australia. Acellular pertussis vaccines are associated with a much lower incidence of fever (20% vs 45%) and local reactions (10% vs 40%) than DTPw vaccine.18 Serious side effects are rare ...
kennel cough - Kipling Veterinary Hospital
... X-rays are done to determine if there is secondary pneumonia. If signs are severe, antibiotics are given, and continued 3-5 days after all symptoms are gone. Hospitalization may be necessary for pneumonia. While showing signs of kennel cough, infected dogs need to be isolated from other dogs to prev ...
... X-rays are done to determine if there is secondary pneumonia. If signs are severe, antibiotics are given, and continued 3-5 days after all symptoms are gone. Hospitalization may be necessary for pneumonia. While showing signs of kennel cough, infected dogs need to be isolated from other dogs to prev ...
Basic Immunology - Pipestone Veterinary Services
... Antigens and Adjuvants: First of all let us review the components a vaccine. A vaccine is made up of two basic components: one or more antigens and an adjuvant. Antigens are proteins that white blood cells recognize and make antibodies against. This helps the immune system recognize these as foreign ...
... Antigens and Adjuvants: First of all let us review the components a vaccine. A vaccine is made up of two basic components: one or more antigens and an adjuvant. Antigens are proteins that white blood cells recognize and make antibodies against. This helps the immune system recognize these as foreign ...
Document
... a. Not quite clear on this part yet. Any suggestions on good sources? 7. Results: a. Mice – strong T cells-mediated immune responses, at least 155 days b. Rhesus macaques – prime-boost elicited HIV-specific T cell responsesiv c. Humans – Phase I and Phase II trials underway in Oxford and Nairobi i. ...
... a. Not quite clear on this part yet. Any suggestions on good sources? 7. Results: a. Mice – strong T cells-mediated immune responses, at least 155 days b. Rhesus macaques – prime-boost elicited HIV-specific T cell responsesiv c. Humans – Phase I and Phase II trials underway in Oxford and Nairobi i. ...
Four Corners Veterinary Hospital uses the Merial™ PUREVAX
... PUREVAX® Feline Rabies vaccine in cats 12 weeks of age or older. Rabies is transmitted mainly through bite wounds of infected mammals. More cats than dogs develop rabies in the United States. Since rabies is a human health concern, all cats (as long as they are deemed healthy by a veterinarian) shou ...
... PUREVAX® Feline Rabies vaccine in cats 12 weeks of age or older. Rabies is transmitted mainly through bite wounds of infected mammals. More cats than dogs develop rabies in the United States. Since rabies is a human health concern, all cats (as long as they are deemed healthy by a veterinarian) shou ...
Vaccines
... sub-clinical or mild disease and that produce long lasting immunity. – Antigen is intact, may decrease circulation of wild type ...
... sub-clinical or mild disease and that produce long lasting immunity. – Antigen is intact, may decrease circulation of wild type ...
MICR 201 Microbiology for Health Related Sciences
... Bacteria, viruses, & fungi cause: Bronchitis Bronchiolitis Pneumonia ...
... Bacteria, viruses, & fungi cause: Bronchitis Bronchiolitis Pneumonia ...
MICR 201 Microbiology for Health Related Sciences
... Bacteria, viruses, & fungi cause: Bronchitis Bronchiolitis ...
... Bacteria, viruses, & fungi cause: Bronchitis Bronchiolitis ...
Tuberculosis – The facts!
... Tuberculosis – The facts! TB is curable but kills 5000 people every day or 2 million per year. 2 billion people (1/3 of world’s population) are infected with the microbes that cause TB 1 in 10 people infected with TB microbes will become sick with active TB in their lifetime TB is contagious & ...
... Tuberculosis – The facts! TB is curable but kills 5000 people every day or 2 million per year. 2 billion people (1/3 of world’s population) are infected with the microbes that cause TB 1 in 10 people infected with TB microbes will become sick with active TB in their lifetime TB is contagious & ...
Consumer Immunisation in pregnancy leaflet (PDF
... whooping cough and having severe, potentially lifethreating complications from the infection in his/ her first few months of life, however, babies younger than six weeks cannot be immunised against whooping cough because their immune system is not developed enough. By getting immunised during pregna ...
... whooping cough and having severe, potentially lifethreating complications from the infection in his/ her first few months of life, however, babies younger than six weeks cannot be immunised against whooping cough because their immune system is not developed enough. By getting immunised during pregna ...
HEPATITIS B VACCINE DECLINATION
... HEPATITIS B VACCINE DECLINATION I understand that due to my occupational exposure to blood or other infectious materials that I may be at risk of acquiring Hepatitis B virus infection. I have been given the opportunity to be vaccinated with the Hepatitis B vaccination at this time. I understand that ...
... HEPATITIS B VACCINE DECLINATION I understand that due to my occupational exposure to blood or other infectious materials that I may be at risk of acquiring Hepatitis B virus infection. I have been given the opportunity to be vaccinated with the Hepatitis B vaccination at this time. I understand that ...
Decreasing vaccine preventable diseases in adults
... 16. RECOGNISES the importance of the general public understanding the value of vaccinations and NOTES that the occasional lack of awareness of the benefits of some vaccines and the increasing refusal of vaccination in some Member States may lead to under-vaccination in some populations resulting in ...
... 16. RECOGNISES the importance of the general public understanding the value of vaccinations and NOTES that the occasional lack of awareness of the benefits of some vaccines and the increasing refusal of vaccination in some Member States may lead to under-vaccination in some populations resulting in ...
Chapter 29 Human Papilloma Virus Infection and Immunity
... • Cervical cancer is the second leading cause of death among women worldwide • Prevention of cervical cancer can be accomplished with the use of an effective HPV vaccine ...
... • Cervical cancer is the second leading cause of death among women worldwide • Prevention of cervical cancer can be accomplished with the use of an effective HPV vaccine ...
Immunity and how vaccines work
... • Frequency of adverse events falls with number of doses • If antibody is made -> neutralises small amount of vaccine virus in any subsequent vaccine dose e.g. MMR Non live vaccines • Frequency of adverse events increases with number of doses • Good antibody levels ->good secondary immune response • ...
... • Frequency of adverse events falls with number of doses • If antibody is made -> neutralises small amount of vaccine virus in any subsequent vaccine dose e.g. MMR Non live vaccines • Frequency of adverse events increases with number of doses • Good antibody levels ->good secondary immune response • ...
T.R.
... recent years, affecting HIV patients and killing them due to their weakened immune systems. ...
... recent years, affecting HIV patients and killing them due to their weakened immune systems. ...
Chapter 24 Active Lecture Questions
... What is the name of the toxin produced by Bordetella pertussis that causes the loss of cilia in the lower respiratory tract? a. b. c. d. ...
... What is the name of the toxin produced by Bordetella pertussis that causes the loss of cilia in the lower respiratory tract? a. b. c. d. ...
Appendix A: Disease-Specific Chapters
... Pertussis outbreaks tend to be cyclical in nature with increased disease activity approximately every 4 - 6 years.3 Protection against pertussis is not lifelong and wanes after 7-20 years of natural infection and approximately 4-12 years after immunization with either whole cell or acellular pertuss ...
... Pertussis outbreaks tend to be cyclical in nature with increased disease activity approximately every 4 - 6 years.3 Protection against pertussis is not lifelong and wanes after 7-20 years of natural infection and approximately 4-12 years after immunization with either whole cell or acellular pertuss ...
Hepatitis B Vaccine
... The minimum age for dose 1 of rotavirus vaccine is 6 weeks; the maximum age for dose 1 is 14 weeks and 6 days. - Efficacy- 85%-98% protective against severe rota virus disease Side effectsA small increase in intussusception cases during the first week after the first dose. Stomach pain, vomiting, bl ...
... The minimum age for dose 1 of rotavirus vaccine is 6 weeks; the maximum age for dose 1 is 14 weeks and 6 days. - Efficacy- 85%-98% protective against severe rota virus disease Side effectsA small increase in intussusception cases during the first week after the first dose. Stomach pain, vomiting, bl ...
worksheet for infectious and communicable diseases
... _H__Epstein-Barr virus; herpes group. Accompanied by hepatosplenomegaly, Fever, tonsillitis, lymphadenopathy. _D__Fifth’s Disease; slapped cheeks. Not contagious after the rash appears; Assoc. with fetal demise with exposure in first trimester. _F__Erythema Migrans; often in the groin, axilla, thigh ...
... _H__Epstein-Barr virus; herpes group. Accompanied by hepatosplenomegaly, Fever, tonsillitis, lymphadenopathy. _D__Fifth’s Disease; slapped cheeks. Not contagious after the rash appears; Assoc. with fetal demise with exposure in first trimester. _F__Erythema Migrans; often in the groin, axilla, thigh ...
LMC model, Hepatitis B - League of Minnesota Cities
... I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline Hepatitis vacc ...
... I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline Hepatitis vacc ...
Hepatitis B Vaccine Declination (Mandatory) I, , understand that due
... Hepatitis B Vaccine Declination (Mandatory) ...
... Hepatitis B Vaccine Declination (Mandatory) ...
licensed under a . Your use of this Creative Commons Attribution-NonCommercial-ShareAlike License
... School of Public Health Infectious disease prevention with the safest vaccines possible Epidemiological studies of vaccinepreventable diseases and phase I, II, and III vaccine trials of hepatitis A and B, inactivated polio virus, pertussis, Haemophilus influenzae type B, tetanus, Lyme disease, rotav ...
... School of Public Health Infectious disease prevention with the safest vaccines possible Epidemiological studies of vaccinepreventable diseases and phase I, II, and III vaccine trials of hepatitis A and B, inactivated polio virus, pertussis, Haemophilus influenzae type B, tetanus, Lyme disease, rotav ...
NSW Health Evidence of Protection Guidelines ( PDF 69.6k)
... Use of accelerated schedules (eg 0, 7, 21 days) is not appropriate and the person will not be considered to have evidence of protection until a fourth dose of vaccine at 12 months is administered. Vaccinated applicants without documented evidence of vaccine doses may not need to recommence the vacci ...
... Use of accelerated schedules (eg 0, 7, 21 days) is not appropriate and the person will not be considered to have evidence of protection until a fourth dose of vaccine at 12 months is administered. Vaccinated applicants without documented evidence of vaccine doses may not need to recommence the vacci ...
Powerful Vaccine Discovery
... reach large populations and prevent endemic disease. Using novel technologies such as flagellin-based fusion proteins, scientists at Wake Forest Baptist Medical Center and Wake Forest University are developing highly potent, cost-effective vaccines that provide protective immunity against a range of ...
... reach large populations and prevent endemic disease. Using novel technologies such as flagellin-based fusion proteins, scientists at Wake Forest Baptist Medical Center and Wake Forest University are developing highly potent, cost-effective vaccines that provide protective immunity against a range of ...